肝脏疾病的补充和替代医学

IF 0.4 4区医学 Q4 NUTRITION & DIETETICS Current Topics in Nutraceutical Research Pub Date : 2022-07-21 DOI:10.37290/ctnr2641-452x.20:666-668

Chun-Hsien Yu, Ya-Hsuan Lin, Ching-Feng Cheng, C. Kuo

{"title":"肝脏疾病的补充和替代医学","authors":"Chun-Hsien Yu, Ya-Hsuan Lin, Ching-Feng Cheng, C. Kuo","doi":"10.37290/ctnr2641-452x.20:666-668","DOIUrl":null,"url":null,"abstract":"Fibrosis in the liver can result in portal hypertension and structural changes, eventually progressing to cirrhosis or hepatocellular carcinoma. Liver fibrosis is caused by the activation of liver hepatic stellate cells. Treatment of liver fibrosis may involve the induction of apoptosis or prevention of activation of activated hepatic stellate cells. A novel therapeutic strategy for treating liver fibrosis caused by hepatic stellate cells may be developed through complementary and alternative therapies. Therefore, in this article, we discuss recent investigations into the complementary and alternative medicine as a means of preventing and treating liver fibrosis.","PeriodicalId":10976,"journal":{"name":"Current Topics in Nutraceutical Research","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Complementary and Alternative Medicine for Liver Diseases\",\"authors\":\"Chun-Hsien Yu, Ya-Hsuan Lin, Ching-Feng Cheng, C. Kuo\",\"doi\":\"10.37290/ctnr2641-452x.20:666-668\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Fibrosis in the liver can result in portal hypertension and structural changes, eventually progressing to cirrhosis or hepatocellular carcinoma. Liver fibrosis is caused by the activation of liver hepatic stellate cells. Treatment of liver fibrosis may involve the induction of apoptosis or prevention of activation of activated hepatic stellate cells. A novel therapeutic strategy for treating liver fibrosis caused by hepatic stellate cells may be developed through complementary and alternative therapies. Therefore, in this article, we discuss recent investigations into the complementary and alternative medicine as a means of preventing and treating liver fibrosis.\",\"PeriodicalId\":10976,\"journal\":{\"name\":\"Current Topics in Nutraceutical Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2022-07-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Topics in Nutraceutical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.37290/ctnr2641-452x.20:666-668\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Topics in Nutraceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37290/ctnr2641-452x.20:666-668","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}

引用次数: 0

摘要

肝纤维化可导致门脉高压和结构改变，最终发展为肝硬化或肝细胞癌。肝纤维化是由肝星状细胞活化引起的。肝纤维化的治疗可能涉及诱导细胞凋亡或防止活化的肝星状细胞的活化。一种新的治疗策略，治疗肝星状细胞引起的肝纤维化可能通过补充和替代治疗发展。因此，在本文中，我们讨论了最近的研究补充和替代医学作为预防和治疗肝纤维化的手段。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Complementary and Alternative Medicine for Liver Diseases

Fibrosis in the liver can result in portal hypertension and structural changes, eventually progressing to cirrhosis or hepatocellular carcinoma. Liver fibrosis is caused by the activation of liver hepatic stellate cells. Treatment of liver fibrosis may involve the induction of apoptosis or prevention of activation of activated hepatic stellate cells. A novel therapeutic strategy for treating liver fibrosis caused by hepatic stellate cells may be developed through complementary and alternative therapies. Therefore, in this article, we discuss recent investigations into the complementary and alternative medicine as a means of preventing and treating liver fibrosis.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current Topics in Nutraceutical Research 医学-药学

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Current Topics in Nutraceutical Research is an international, interdisciplinary broad-based peer reviewed scientific journal for critical evaluation of research on chemistry, biology and therapeutic applications of nutraceuticals and functional foods. The major goal of this journal is to provide peer reviewed unbiased scientific data to the decision makers in the nutraceutical and food industry to help make informed choices about development of new products. To this end, the journal will publish two types of review articles. First, a review of preclinical research data coming largely from animal, cell culture and other experimental models. Such data will provide basis for future product development and/or human research initiatives. Second, a critical evaluation of current human experimental data to help market and deliver the product for medically proven use. This journal will also serve as a forum for nutritionists, internists, neurologists, psychiatrists, and all those interested in preventive medicine. The common denominator of all of the topic to be covered by the journal must include nutraceuticals and/functional food. The following is an example of some specific areas that may be of interest to the journal. i) Role of vitamins, minerals, antioxidants and phytonutrients on cardiovascular health, cancer, diabetes, ocular health, mental health, men’s health, women’s health, infant nutrition, ii) Role of herbals on human health, iii) Dietary supplements and sleep, iv) Components of diet that may have beneficial effect on human health, v) regulation of apoptosis and cell viability, vi) Isolation and characterization of bioactive components from functional foods, vii) Nutritional genomics, and viii) Nutritional proteomics.